Barely Significant
← all excerpts

Assessment of <sup>213</sup>Bi-anti-EGFR MAb treatment efficacy in malignant cancer cells with [1-<sup>13</sup>C]pyruvate and [<sup>18</sup>F]FDG.

Sci Rep · 2019 · PMC6549183 · PMID 31165773

Europe PMCDOI
2
hedged sentences
0.0591
closest p · 1.2× alpha
0.0591
boldest claim

The sentences

showed a trendp = 0.0591so close (0.05 < p ≤ 0.1)
In LN18 cells 213 Bi-anti-EGFR-MAb treatment induced also an increase, which showed a trend towards statistical significance (p = 0.0591): analysis of cell culture medium revealed a LDH activity of 31.1 ± 5.4 ng/ml and 46.6 ± 7,3 ng/ml for controls and 213 Bi-anti-EGFR-MAb treated cells, respectively.

also in 53,322 other papers

a clear trendno p-value reported
Nevertheless, a clear trend towards a reduction of [ 18 F]FDG uptake was registered, constituting approx. 23%.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.